Acadia Healthcare Company acquired Priory Group No. 1 Limited for approximately $2.2 billion (total purchase price); ~$1.9B cash plus 4,033,561 Acadia shares, a transaction completed in February 2016, structured as combination (cash plus stock); ~£1.275 billion (~$1.887B) cash, including ~£925M to repay Priory debt, plus Acadia common stock.
Priory Group No. 1 Limited operates in United Kingdom behavioral health, is based in United Kingdom — 327 facilities, ~7,100 beds (at December 31, 2015), had revenue of about approximately $865 million expected 2015 revenue; ~$196 million adjusted EBITDA. On February 16, 2016 Acadia completed the acquisition of Priory Group, the leading independent provider of behavioral healthcare services in the United Kingdom, for a total purchase price of approximately $2.2 billion — including total cash consideration of approximately $1.9 billion and the issuance of 4,033,561 shares of Acadia common stock. Priory operated 327 facilities with approximately 7,100 beds at December 31, 2015 and was expected to produce 2015 revenue of approximately $865 million and adjusted EBITDA of approximately $196 million. The deal made Acadia (with PiC) the leading independent provider of mental health services in the U.K.
“Acadia Healthcare to Acquire Priory Group, a Leading Provider of Behavioral Healthcare Services in the United Kingdom ... Will Expand Acadia's U.K. Presence by Over 300 Facilities with Approximately 7,200 Beds. Expected Annualized Accretion in Range of $0.38 to $0.42 per Diluted Share.”
Leading independent UK behavioral healthcare provider; combined with PiC it made Acadia the U.K. market leader, with expected annualized accretion of $0.38-$0.42 per diluted share. Expected annualized EPS accretion of $0.38 to $0.42 per diluted share; U.K. scale leadership. Priory Group (Acadia U.K. operations)
Priory is a leading provider of behavioral healthcare services in the United Kingdom, operating more than 300 facilities with approximately 7,200 beds. For 2015, Priory is expected to produce revenue of approximately $865 million and adjusted EBITDA of approximately $196 million.Acadia Healthcare press release, January 4, 2016
Advisory firms were not disclosed for this transaction.